Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Upgrades Edwards Lifesciences (EW) to Overweight
-
Piper Jaffray & Canaccord Genuity Initiates Coverage on China Kanghui Holdings (KH)
-
Notable Analyst Rating Changes 09/17: VITA, ORCL, CTL, OSK Upgraded; ARNA, MELI, ARRS, SPN Downgraded
-
Piper Jaffray Initiates Coverage on Quanta Services (PWR) with an 'Overweight'
-
Piper Jaffray Initiates Coverage on PolyOne (POL) with an Overweight
-
Piper Jaffray Cuts Arena Pharma (ARNA) to Neutral, Price Target Slashed to $1.50
-
Piper Jaffray Downgrades Shire plc (SHPGY) to Neutral
-
Liberty Mutual Agency (LMAC) Sees 64.31M IPO Price of $18 - $20/Share
-
Piper Jaffray Initiates Coverage on Hill-Rom Holdings (HRC) with an Overweight
-
Piper Jaffray Initiates Coverage on Orthofix International (OFIX) with a Neutral
-
Piper Jaffray Upgrades Stryker Corp. (SYK) to Overweight
-
Jefferies, BMO Issue Afternoon Downgrades on Arena Pharma (ARNA)
-
Analyst Round-Up Arena Pharma (ARNA): Downgraded at Barclays, Oppenheimer, Defended by Piper Jaffray
-
Piper Jaffray Says Arena Pharmaceuticals (ARNA) Sell-Off is an "Overreaction"
-
Piper Jaffray Maintains an 'Overweight' on Power Integrations (POWI); Pre-Announced Q3 on Weak Consumer Demand
-
Piper Jaffray Maintains an 'Overweight' Rating on Amazon.com (AMZN); Early Thoughts On Sep Quarter
-
Piper Jaffray Downgrades Informatica (INFA) to Neutral; Solid Franchise for Long Haul, But Risk/Reward No Longer Asymmetric
-
Piper Jaffray Downgrades TIBCO Software (TIBX) to Neutral; Solid Franchise for Long Haul, But Risk/Reward No Longer Asymmetric
-
Piper Jaffray Downgrades salesforce.com (CRM) to Neutral; Sector Call & Valuation
-
Piper Jaffray Downgrades Red Hat (RHT) to Neutral; Sector Call & Current Valuation
-
Piper Jaffray Initiates Coverage on Gordmans Stores (GMAN) with an 'Overweight'; Attractive New Unit Economics, Returns, and Payback Period
-
Elster Group (ELT) Sees IPO Price of $16 - $18/ADS
-
Notable 52-Week High's and Low's of the Day 09/13: ATML, ENTR, BEAV High; V, DYP, DGW, MA Low
-
Ahead of NPD Data Release Today, Piper Jaffray Sees 15% Mac Growth, Flat to Down 5% iPod Units in August
-
Piper Jaffray Maintains an 'Overweight' Rating on Netflix (NFLX); Adjusting Estimates For Increasing Use Of Watch Instantly
-
Notable Analyst Rating Changes 09/13: KMX, NOK, HBAN, UAUA Upgraded; XOM, MA, HGSI, V Downgraded
-
Piper Jaffray Downgrades Duoyuan Global Water (DGW) to Underweight; Guilty by Association; Internal Control Concern
-
Piper Jaffray Downgrades Duoyuan Printing (DYP) to Underweight Following Management Departures
-
Morning Movers 09/13: GTSI, CYCC, ARST, TSRX, OCCF, ENTR Higher; DYP, DGW, BDCO Lower
-
Piper Jaffray Initiates Coverage on Trius Therapeutics (TSRX) with an 'Overweight'; Torezolid a Promising Novel Antibiotic
-
Piper Jaffray Starts Dress Barn (DBRN) at Overweight Ahead of Q4 Results
-
Piper Jaffray Tells Traders to 'Buy the Dip' in Crocs (CROX); Call Not Looking So Good Today, Shares Down 7%
-
Notable Analyst Rating Changes 09/10: MCO, NOK, CCE, ALL Upgraded; DELL, CSCO, ADBE, SFD Downgraded
-
Piper Jaffray Initiates Coverage on TeleNav, Inc. (TNAV) with a Neutral; Mobile Navigation Leader
-
Piper Jaffray Upgrades Moody's (MCO) to Overweight
-
Notable Mergers and Acquisitions of the Day 09/09: SNY/GENZ, MMM, EMMS
-
3M (MMM) Announces $810M Acquisition of Arizant Inc.; Sees Transaction Neutral to EPS
-
Piper Jaffray Downgrades Numerous Education Stocks Amid Concerns with Regulatory Compliance (ESI, CPLA, BPI, APOL, EDMC)
-
Morning Movers 09/08: ZGEN, EDAP, QXM, HDY, TUNE, ROIAK, SKH Higher; CAGC, DFZ, ALTI Lower
-
Phillips-Van Heusen (PVH) Upside Accelerates After Strong Results
-
Daily State of the Markets: Surprised and Frightened?
-
Piper Jaffray Initiates Coverage on Molycorp (MCP) with a Neutral; Promising 'Mine to Magnets' Prospects Balance Timing Risk
-
Piper Jaffray Upgrades Phillips-Van Heusen (PVH) to Overweight; Calvin Klein/Tommy Hilfiger Drive Estimates Higher
-
Notable Analyst Rating Changes 09/07: ORCL, NETL, GBG, NOK Upgraded; CPB, TXN, LYV, ONNN Downgraded
-
Piper Jaffray Tells Clients to Buy Arena Pharmaceuticals (ARNA) Ahead of 9/16 FDA FDA Meeting
-
Piper Jaffray Initiates Coverage on Green Dot Corporation (GDOT) with an Overweight; Transforming Financial Services For The Underbanked
-
Notable Analyst Rating Changes 09/03: BKE, KSP, DRIV, LAYN Upgraded; MITL, BKC, TTWO, AEO Downgraded
-
Piper Jaffray Reiterates an 'Overweight' Rating on Starbucks (SBUX); Coffee Price Concern Potentially Overdone
-
Piper Jaffray Maintains an 'Overweight' Rating on Panera Bread (PNRA); Near-Term Pressure from Wheat Volatility Overdone
-
Piper Jaffray Maintains 'Neutral' on Take-Two Interactive (TTWO); Serious Earnings; Holiday Line-Up Improves
